Versant Capital Management, Inc - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 240 filers reported holding NEKTAR THERAPEUTICS in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2023$95
-78.8%
169
-77.5%
0.00%
Q3 2023$448
+3.5%
7520.0%0.00%
Q2 2023$433
-9.4%
7520.0%0.00%
Q1 2023$478
-92.9%
752
-74.6%
0.00%
-100.0%
Q4 2022$6,699
+67.5%
2,964
+157.5%
0.00%0.0%
Q3 2022$4,000
+33.3%
1,151
+56.0%
0.00%
+100.0%
Q2 2022$3,0000.0%738
+36.4%
0.00%0.0%
Q1 2022$3,000541
+5911.1%
0.00%
Q4 2021$090.0%0.00%
Q3 2021$090.0%0.00%
Q2 2021$090.0%0.00%
Q1 2021$090.0%0.00%
Q4 2020$090.0%0.00%
Q3 2020$090.0%0.00%
Q2 2020$090.0%0.00%
Q1 2020$0
-100.0%
9
-80.9%
0.00%
-100.0%
Q4 2019$1,000470.0%0.00%
Q3 2019$0
-100.0%
47
-33.8%
0.00%
-100.0%
Q2 2019$2,000
-87.5%
71
-71.4%
0.00%
-66.7%
Q1 2019$16,000
-48.4%
248
-74.3%
0.00%
-78.6%
Q4 2018$31,000
-50.8%
966
-7.6%
0.01%
-46.2%
Q3 2018$63,000
-32.3%
1,045
-45.7%
0.03%
-33.3%
Q2 2018$93,000
-58.3%
1,924
-8.6%
0.04%
-57.6%
Q1 2018$223,000
+60.4%
2,104
-10.1%
0.09%
+64.3%
Q4 2017$139,000
+189.6%
2,341
+15.9%
0.06%
+115.4%
Q3 2017$48,000
+118.2%
2,020
+75.3%
0.03%
+116.7%
Q2 2017$22,000
+37.5%
1,152
+61.1%
0.01%
+33.3%
Q1 2017$16,000715
+7844.4%
0.01%
Q4 2016$09
-83.3%
0.00%
Q3 2016$0540.0%0.00%
Q2 2016$0540.0%0.00%
Q1 2016$0540.0%0.00%
Q4 2015$0540.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2021
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 1,828,400$89,281,0006.61%
Cormorant Asset Management, LP 1,500,000$73,245,0005.42%
Camber Capital Management LP 2,000,000$97,660,0003.76%
Rhenman & Partners Asset Management AB 617,652$30,160,0003.09%
BRIDGER MANAGEMENT, LLC 1,134,414$55,393,0003.00%
First Light Asset Management, LLC 374,251$18,275,0002.84%
Gs Investments, Inc. 54,000$2,636,820,0001.97%
SABBY MANAGEMENT, LLC 241,922$11,813,0001.82%
QUANTRES ASSET MANAGEMENT Ltd 50,000$2,441,0001.41%
Tibra Equities Europe Ltd 173,183$8,457,0001.27%
View complete list of NEKTAR THERAPEUTICS shareholders